| Oct 24 |
Metagenomi Presents Novel, Highly Specific and Efficient Adenine Base Editors for Broad Genome Editing at ESGCT
|
| Oct 15 |
Metagenomi Presents Compact SMART Editing Platform at AIChE 7th International Conference on CRISPR Technologies
|
| Sep 19 |
Metagenomi to Present at Chardan's 8th Annual Genetic Medicines Conference
|
| Sep 18 |
We Think Metagenomi (NASDAQ:MGX) Needs To Drive Business Growth Carefully
|
| Sep 17 |
BlackRock, Microsoft, Others Team Up For $30B Artificial Intelligence Fund: Help US Fuel 'AI Innovation And Economic Growth'
|
| Sep 3 |
Metagenomi Announces Preclinical Data for Lead Hemophilia A Program Demonstrating Durable Factor VIII (FVIII) Activity Levels through Twelve Months
|
| Aug 29 |
Metagenomi Presents AI-Enabled Advancements of SMART Editing Platform at the Cold Spring Harbor Laboratory CRISPR Frontiers Conference
|
| Aug 28 |
Metagenomi to Participate in Upcoming Investor Conferences
|
| Aug 15 |
Metagenomi, Inc. GAAP EPS of -$0.29, revenue of $20M
|
| Aug 14 |
Metagenomi: Q2 Earnings Snapshot
|
